Lapatinib in advanced chordoma: A phase II study

被引：0
|
作者：
Stacchiotti, Silvia
Tamborini, Elena
Palassini, Elena
Negri, Tiziana
Marrari, Andrea
Messina, Antonella
Morosi, Carlo
De Troia, Beatrice
Longhi, Alessandra
Palmerini, Emanuela
Gronchi, Alessandro
Pilotti, Silvana
Casali, Paolo Giovanni
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Ist Ortoped Rizzoli, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10026
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A randomized phase II study of lapatinib plus pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
    Cristofanilli, Massimo
    Johnston, Stephen R. D.
    Manikhas, Alexey
    Gomez, Henry L.
    Gladkov, Oleg
    Shao, Zhimin
    Safina, Sufia
    Blackwell, Kimberly L.
    Alvarez, Ricardo H.
    Rubin, Stephen D.
    Ranganathan, Sulabha
    Redhu, Suman
    Trudeau, Maureen E.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 471 - 482
  • [32] Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study
    Frentzas, S. N.
    Groves, M. D.
    Barriuso, J.
    Harris, D.
    Reardon, D.
    Curtis, M. C.
    Suttle, A. B.
    Ma, B.
    Lager, J. J.
    de Bono, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    de Souza, Jonas A.
    Davis, Darren W.
    Zhang, Yujian
    Khattri, Arun
    Seiwert, Tanguy Y.
    Aktolga, Serdal
    Wong, Stuart J.
    Kozloff, Mark F.
    Nattam, Sreenivasa
    Lingen, Mark W.
    Kunnavakkam, Rangesh
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Bozeman, Jeffrey
    Dancey, Janet E.
    Vokes, Everett E.
    Cohen, Ezra E. W.
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2336 - 2343
  • [34] Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer
    Kimple, R. J.
    Sartor, C. I.
    Chiu, W. M.
    Esler, L.
    Livasy, C. A.
    Carey, L. A.
    Halle, J.
    Dees, E. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S210 - S210
  • [35] Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors
    de Jonge, Maja J. A.
    Hamberg, Paul
    Verweij, Jaap
    Savage, Shawna
    Suttle, A. Benjamin
    Hodge, Jeffrey
    Arumugham, Thangam
    Pandite, Lini N.
    Hurwitz, Herbert I.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 751 - 759
  • [36] A phase I study of capecitabine, oxaliplatin (CapOx), and lapatinib (L) in metastatic or advanced solid tumors
    Dennie, T.
    Alberti, D.
    Oliver, K.
    LoConte, N.
    Mulkerin, D.
    Wilding, G.
    Holen, K.
    Fleming, R.
    Bowen, C.
    O'Neill, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer
    Kimple, Randall J.
    Horton, Janet K.
    Livasy, Chad A.
    Shields, Janiel M.
    Lawrence, Julia A.
    Chiu, WingKeung M.
    Ivanova, Anastasia
    Ollila, David W.
    Carey, Lisa A.
    Halle, Jan S.
    Sartor, Carolyn I.
    Dees, E. Claire
    ONCOLOGIST, 2012, 17 (12): : 1496 - 1503
  • [38] A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer
    Sridhar, Srikala S.
    Hotte, Sebastien J.
    Chin, Joseph L.
    Hudes, Gary R.
    Gregg, Richard
    Trachtenberg, John
    Wang, Lisa
    Tran-Thanh, Danh
    Pham, Nhu-An
    Tsao, Ming-Sound
    Hedley, David
    Dancey, Janet E.
    Moore, Malcolm J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 609 - 613
  • [39] Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors
    Maja J. A. de Jonge
    Paul Hamberg
    Jaap Verweij
    Shawna Savage
    A. Benjamin Suttle
    Jeffrey Hodge
    Thangam Arumugham
    Lini N. Pandite
    Herbert I. Hurwitz
    Investigational New Drugs, 2013, 31 : 751 - 759
  • [40] A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer
    LaBonte, Melissa J.
    Yang, Dongyun
    Zhang, Wu
    Wilson, Peter M.
    Nagarwala, Yasir M.
    Koch, Kevin M.
    Briner, Colleen
    Kaneko, Tomomi
    Rha, Sun-Young
    Gladkov, Oleg
    Urba, Susan G.
    Sakaeva, Dina
    Pishvaian, Michael J.
    Hsieh, Ruey-Kuen
    Lee, Wei-Ping
    Lenz, Heinz-Josef
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (09) : 2251 - 2258
12345